How Do Screening Methods for Gestational Diabetes Compare?

March 10th 2021, 10:00pm


When comparing 1-step and 2-step approaches for diagnosing gestational diabetes among pregnant women, researchers found no significant between-group differences in the risks of primary outcomes relating to perinatal and maternal complications.

Costs for Commercially Insured Adults Prescribed Second-line Diabetes Medications

March 9th 2021, 2:00pm


Adults with type 2 diabetes who received nonsulfonylurea medications had relative increases in total costs. Receiving newer medication classes led to relatively decreased medical costs.

Exercise Timing Linked to Cardiorespiratory Fitness in Men With T2D

March 2nd 2021, 5:05pm


Timing of bout-related moderate-to-vigorous physical activity (MVPA) is associated with cardiorespiratory fitness and cardiovascular risk among men with type 2 diabetes (T2D), independent of bout-related MVPA volume and intensity, according to research published in Diabetes Care.

Use of Diabetes Medications in Traditional Medicare and Medicare Advantage

March 2nd 2021, 2:00pm


Medicare Advantage enrollees are more likely to be treated with metformin and sulfonylureas and less likely to receive costly newer medications than those in traditional Medicare.

Caring for the Whole Patient With Diabetes Drives ChristianaCare Pilot Success

March 1st 2021, 4:39pm


Collaboration enabled ChristianaCare to significantly grow its population of patients with well-controlled disease, thanks to a diabetes control roadmap that ensured both physical and emotional health needs were met through interprofessional partnerships.

Mendelian Randomization Study Shows Vitamin D Deficiency Not Associated With T1D

February 25th 2021, 7:00pm


Genetically decreased vitamin D levels are unlikely to have a large effect on risk of type 1 diabetes, according to results of a Mendelian randomization study published in PLOS Medicine.

How Does Maternal Diet Impact Childhood Weight?

February 22nd 2021, 7:15pm


Low-quality maternal diets may increase the odds of offspring being considered overweight or obese, according to study results published in BMC Medicine.

Phase 3 Trials Show Lilly’s Tirzepatide Reduces A1C, Body Weight Among Patients With T2D

February 18th 2021, 5:25pm


The SURPASS program, which consists in part of SURPASS-3 and SURPASS-5, is testing the efficacy and safety of tirzepatide, a novel investigational once-weekly dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist.

Trial Finds Semaglutide With Lifestyle Intervention Reduces Body Weight by Nearly 15%

February 10th 2021, 10:00pm


In the placebo-controlled trial, 86% of participants who received semaglutide attained at least a 5% reduction in total body weight.

ChristianaCare Innovates Diabetes Care for Patients With Poorly Controlled Disease

February 9th 2021, 1:44pm


On this episode of Managed Care Cast, we speak with experts from ChristianaCare, which implemented a diabetes pilot program at 4 of its primary care sites in 2019 and saw its population of patients with well-controlled disease grow by 16%.